Search details
1.
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial.
Cancer Sci
; 114(8): 3342-3351, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37139543
2.
Risk of bleeding associated with transbronchial biopsy using flexible bronchoscopy in patients with echocardiographic or chest CT evidence of pulmonary hypertension.
BMC Pulm Med
; 22(1): 449, 2022 Nov 28.
Article
in English
| MEDLINE | ID: mdl-36443763
3.
A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101).
Int J Clin Oncol
; 23(6): 1060-1069, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30027464
4.
A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors.
Jpn J Clin Oncol
; 47(4): 298-305, 2017 Apr 01.
Article
in English
| MEDLINE | ID: mdl-28158463
5.
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
Invest New Drugs
; 33(3): 641-51, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25809858
6.
Significantly Delayed Development of Polyarthritis with Active Tenosynovitis after Possible Temporary Neutropenic Immune-Related Adverse Events Caused by Atezolizumab Treatment: A Novel Case Report.
Case Rep Oncol Med
; 2024: 1566299, 2024.
Article
in English
| MEDLINE | ID: mdl-38361964
7.
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.
JAMA Oncol
; 10(4): 439-447, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38451530
8.
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.
Invest New Drugs
; 31(3): 677-84, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-22843211
9.
Temporary Severe Neutropenia during Administration of Atezolizumab: A Novel Case Report.
Case Rep Oncol
; 16(1): 372-377, 2023.
Article
in English
| MEDLINE | ID: mdl-37384199
10.
A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS).
Clin Lung Cancer
; 24(4): 371-375, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36849264
11.
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study.
Eur J Cancer
; 185: 83-93, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36966696
12.
Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.
Cancer Med
; 12(10): 11525-11541, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36999734
13.
A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors.
Cancer Sci
; 103(3): 504-9, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22145984
14.
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer.
Invest New Drugs
; 30(4): 1548-56, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-21748299
15.
The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer.
Oncology
; 82(6): 341-6, 2012.
Article
in English
| MEDLINE | ID: mdl-22677909
16.
Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non-small cell lung cancer.
Eur J Cancer
; 160: 227-234, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34862083
17.
Innovator and generic cisplatin formulations: comparison of renal toxicity.
Cancer Sci
; 102(1): 162-5, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-21054679
18.
Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial.
Eur J Cancer
; 149: 14-22, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33813328
19.
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801).
Clin Lung Cancer
; 22(2): 147-151, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33199228
20.
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002).
Sci Rep
; 11(1): 23140, 2021 11 30.
Article
in English
| MEDLINE | ID: mdl-34848786